180 Wealth Advisors’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

180 Wealth Advisors’s Portfolio OCEA Stock Details OCEA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-25,288	Closed	-$1.37K	–	440
2025 Q1	$1.37K	Buy	+25,288	New	+$6.04K	﹤0.01%	413

Other funds holding OCEA

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

VPIM

Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

SMA

Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return

180 Wealth Advisors's OCEA Position: Q2 2025 in Review

180 Wealth Advisors sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q2 2025, closing a stake of 25,288 shares — an estimated $1.37K sold.

180 Wealth Advisors first reported a position in OCEA in Q1 2025 and held it in 1 quarter. The position peaked at $1.37K in Q1 2025. 7 funds tracked by Wall St. Rank hold OCEA as of Q2 2025.

180 Wealth Advisors reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
180 Wealth Advisors sold 25,288 Ocean Biomedical, Inc. Common Stock shares in Q2 2025, an estimated $1.37K.
180 Wealth Advisors first reported a position in Ocean Biomedical, Inc. Common Stock in Q1 2025 and held it in 1 quarter.
180 Wealth Advisors's Ocean Biomedical, Inc. Common Stock position peaked at $1.37K in Q1 2025.
7 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q2 2025.

Based on 180 Wealth Advisors's 13F filing for Q2 2025, filed 31 Jul 2025.